nstd231 (Ali et al. 2023)
- Organism:
- Human
- Study Type:
- Collection
- Submitter:
- HassanĀ Ali
- Description:
- To facilitate future clinical use of induced pluripotent stem cells (iPS), culturing protocols must be compliant with good manufacturing practice guidelines and devoid of xenogenic products. Hence, we aimed to compare the efficiency of using a xeno-free protocol (protocol utilizing platelet lysate in culture media) to a xenogenic one (protocol utilizing fetal bovine serum in culture media) for iPS generation. Chromosome microarray analysis was performed to determine the effect of each protocol on the genomic integrity of each generated iPS cell line. See Variant Summary counts for nstd231 in dbVar Variant Summary.